• Register
  • Login
  • Subscribe
  • Contact Us

Framework Agreement for the Supply of the Medicines Thiotepa, Liposomal Doxorubicin, Rituximab, Trastuzumab, Bevacizumab, Bortezomib and Ranibizumab

BelgiumTenders notice for Framework Agreement for the Supply of the Medicines Thiotepa, Liposomal Doxorubicin, Rituximab, Trastuzumab, Bevacizumab, Bortezomib and Ranibizumab. The reference ID of the tender is 95701013 and it is closing on 06 Feb 2024.

Tender Details

  • Country: Belgium
  • Summary: Framework Agreement for the Supply of the Medicines Thiotepa, Liposomal Doxorubicin, Rituximab, Trastuzumab, Bevacizumab, Bortezomib and Ranibizumab
  • BET Ref No: 95701013
  • Deadline: 06 Feb 2024
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: EUR 1995000.00
  • Notice Type: Tender
  • Document Ref. No.: 48115-2024
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Framework agreement for the supply of the medicines thiotepa, liposomal doxorubicin, rituximab, trastuzumab, bevacizumab, bortezomib and ranibizumab
    Thiotepa powder for solution 15 mg and 100 mg
    Liposomal doxorubicin solution 2 mg/ml 10 ml and 25 ml
    Rituximab solution vial 100 mg/10 ml and 500 mg/50ml
    Trastuzumab powder for solution 150mg
    Bevacizumab solution 100mg/4ml and 400mg/16ml
    Bortezomib solution 3.5mg/1.4ml
    Ranibizumab solution 10mg/ml
    Doc Title: Framework agreement for the supply of the medicines thiotepa, liposomal doxorubicin, rituximab, trastuzumab , bevacizumab, bortezomib en ranibizumab
    Contract Type: supplies
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Framework Agreement for the Supply of the Medicines Thiotepa, Liposomal Doxorubicin, Rituximab, Trastuzumab, Bevacizumab, Bortezomib and Ranibizumab - Belgium Tender

The THE ANTWERP HOSPITAL NETWORK (ZNA) VZW, a Government sector organization in Belgium, has announced a new tender for Framework Agreement for the Supply of the Medicines Thiotepa, Liposomal Doxorubicin, Rituximab, Trastuzumab, Bevacizumab, Bortezomib and Ranibizumab. This tender is published on BelgiumTenders under BET Ref No: 95701013 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-02-06.

The estimated tender value is EUR 1995000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

BelgiumTenders Features

BelgiumTenders Features

Fresh and verified Tenders from Belgium. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting BelgiumTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Belgium in your email inbox.

  Chat with us